Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03656263
Other study ID # TECHNO-MULTI
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 14, 2018
Est. completion date February 20, 2021

Study information

Verified date February 2021
Source Montreal Heart Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Portal flow pulsatility detected by Doppler ultrasound is an echographic marker of cardiogenic portal hypertension from right ventricular failure and is associated with adverse outcomes based on previous studies performed at the Montreal Heart Institute. This multicenter prospective cohort study aims to determine if portal flow pulsatility after cardiopulmonary bypass separation is associated with a longer requirement of life support after cardiac surgery.


Description:

Hypothesis: Portal flow pulsatility detected by Doppler ultrasound during cardiac surgery is an echographic marker of cardiogenic portal hypertension from right ventricular failure and is associated with adverse clinical outcomes. Background: Peri-operative right ventricular failure is associated with a high mortality rate. In this context, organ perfusion is hampered by both the reduction of cardiac output and venous congestion from the elevation of central venous pressure. The clinician's objective is to appreciate the hemodynamic impact on end-organs in an effort to adjust the therapy accordingly since the ultimate goal is to optimize their perfusion. Based on this rationale, organ specific blood flow assessment using Doppler ultrasound could be used to personalize management. In order to non-invasively assess the presence of cardiogenic portal hypertension, Doppler ultrasound can be used to detect portal flow pulsatility, an abnormal variation in the velocity of blood flow within the main portal vein. In two single-center cohort studies, the presence of portal flow pulsatility after cardiac surgery was independently associated with post-operative complications such as major bleeding, acute kidney injury (AKI) and delirium as well as increased length of intensive care unit (ICU) stay. Specific Objectives: This multi-center cohort study aim to determine whether the association between portal flow pulsatility and organ dysfunction seen in previous studies is present across multiple cardiac surgery centers.


Recruitment information / eligibility

Status Completed
Enrollment 360
Est. completion date February 20, 2021
Est. primary completion date February 20, 2021
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patients (=18 years old) and able to give informed consent undergoing cardiac surgery with the use of CPB for whom peri-operative TEE is planned. - High surgical risk defined as at least one of the following: 1. Multiple surgical procedures planned 2. EuroSCORE II = 5% 3. Known pulmonary hypertension (mPAP>25mmHg or sPAP>40mmHg). Exclusion Criteria: - Patient with a critical pre-operative state defined as vasopressor requirement, mechanical circulatory support, dialysis, mechanical ventilation or cardiac arrest necessitating resuscitation. - Patient with known condition that could interfere with portal flow assessment or interpretation (liver cirrhosis, portal vein thrombosis) - Planned cardiac transplantation - Planned ventricular assist device implantation

Study Design


Intervention

Diagnostic Test:
Doppler assessment of portal vein flow
Doppler assessment of portal vein flow using peri-operative trans-esophageal echography before and after cardiopulmonary bypass.

Locations

Country Name City State
Canada Montreal Heart Institute Montreal Quebec

Sponsors (1)

Lead Sponsor Collaborator
Montreal Heart Institute

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Duration of invasive life support after cardiac surgery. (Tpod) Defined as the time of Persistent Organ Dysfunction (POD) or Death Up to 28 days
Secondary All cause death Death from any cause Up to 28 days
Secondary Acute kidney injury according to KDIGO serum creatinine criteria Stage 1: =50% or 27 umol/L increases in serum creatinine Stage 2: =100% increase in serum creatinine Stage 3 =200% increase in serum creatinine or an increase to a level of =254 umol/L or dialysis initiation. Up to 28 days
Secondary Major bleeding defined by the Bleeding Academic Research Consortium (BARC) Perioperative intracranial bleeding within 48h Reoperation after closure of sternotomy for the purpose of controlling bleeding Transfusion of =5 units of whole blood of packed red blood cells within a 48 hours period Chest tube output =2L within a 24 hours period Up to 28 days
Secondary Surgical reintervention for any reasons Re-operation after the initial surgery for any cause Up to 28 days
Secondary Deep sternal wound infection or mediastinitis Diagnosis of a deep incisional surgical site infection or mediastinitis by a surgeon or attending physician. Up to 28 days
Secondary Delirium Defined as a intensive care delirium screening checklist (ICDSC) score of =4 in the week following surgery or positive result for the Confusion Assessment Method for the ICU (CAM-ICU) Up to 28 days
Secondary Stroke A central neurologic deficit persisting longer than 72 hours Up to 28 days
Secondary Total duration of ICU stay in hours Number of hours passed in the ICU Up to 28 days
Secondary Duration of hospital stay (in days) Number of days hospitalized from the day of surgery to discharge Up to 28 days
Secondary Duration of mechanical ventilation (in hours) Number of hours of mechanical ventilation Up to 28 days
Secondary A composite outcome of major morbidity or mortality (41): including death, prolonged ventilation, stroke, renal failure (Stage =2), deep sternal wound infection and reoperation for any reason. Composite endpoint after cardiac proposed by the Society of Thoracic Surgeons Up to 28 days
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04279054 - Decreased Neuraxial Morphine After Cesarean Delivery Early Phase 1
Active, not recruiting NCT04580030 - Tricuapid Annular Plane Sistolic Excursion Before General Anesthesia Can Predict Hypotension After Induction
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Recruiting NCT04099693 - A Prospective Randomized Study of General Anesthesia Versus Anesthetist Administered Sedation for ERCP
Terminated NCT02481999 - Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years
Completed NCT04235894 - An Observer Rating Scale of Facial Expression Can Predict Dreaming in Propofol Anesthesia
Recruiting NCT05525104 - The Effect of DSA on Recovery of Anaesthesia in Children (Het Effect Van DSA op Het Herstel na Anesthesie Bij Kinderen). N/A
Recruiting NCT05024084 - Desflurane and Sevoflurane Minimal Flow Anesthesia on Recovery and Anesthetic Depth Phase 4
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03277872 - NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope N/A
Terminated NCT03940651 - Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase 4
Terminated NCT02529696 - Measuring Sedation in the Intensive Care Unit Using Wireless Accelerometers
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Terminated NCT03704285 - Development of pk/pd Model of Propofol in Patients With Severe Burns
Recruiting NCT05259787 - EP Intravenous Anesthesia in Hysteroscopy Phase 4
Completed NCT02894996 - Does the Response to a Mini-fluid Challenge of 3ml/kg in 2 Minutes Predict Fluid Responsiveness for Pediatric Patient? N/A
Completed NCT05386082 - Anesthesia Core Quality Metrics Consensus Delphi Study
Terminated NCT03567928 - Laryngeal Mask in Upper Gastrointestinal Procedures N/A
Recruiting NCT06074471 - Motor Sparing Supraclavicular Block N/A
Completed NCT04163848 - CARbon Impact of aNesthesic Gas